Get in touch
We'd love to hear from you. Whether you have a question, would like to share your story, explore collaboration, or simply want to say hello, please get in touch.
We will treat your information confidentially and only share it with your permission, or in the limited circumstances explained in our Privacy Policy.
We understand some people sharing stories may not wish to be publicly identified. If so, simply leave the last name blank.
How we use personal experiences
DAAG values lived experience as an important source of evidence about the impact of dopamine agonists. We distinguish between personal accounts, allegations, clinical or scientific evidence, official information and established findings. Where someone reports that a particular behaviour or harm was associated with dopamine agonist treatment, we will accurately represent this as their reported experience unless there is independent evidence supporting a stronger conclusion.
DAAG does not investigate allegations or make determinations of criminal responsibility, civil liability or individual clinical causation. When communicating individual experiences, we take reasonable steps to ensure that our description is accurate in context, fair and not misleading, and that the privacy and rights of contributors and other people mentioned in their accounts are appropriately protected.